The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the available information the cause of the reported thrombus cannot be determined.The reported thrombus as listed in the mitraclip system instructions for use (ifu) is a known possible complication associated with mitraclip procedures.The reported medication is the result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
It was reported the procedure was performed to treat functional mitral regurgitation (mr) with a grade of 2-3.An xtw clip was inserted and grasping was performed, but a small floating structure was observed at the clip/delivery catheter shaft despite heparin injection and sufficient activated clotting time (act).Act maintained above 250 seconds throughout the procedure.Therefore, the physician decided to administer an additional heparin bolus.It was noted the structure was no longer detected.The clip was successfully implanted, reducing mr to a grade of <1.There was no clinically significant delay in the procedure.
|